 BiomX Inc NYSE: PHGE has announced a new collaboration with Boehringer Ingelheim to identify biomarkers for inflammatory bowel disease IBD. BiomX is a clinical-stage microbiome company advancing novel natural and engineered phage therapies that target specific. 